Prescription RequiredAbiraterone Acetate 500 mg (Bdron) is an anticancer medicine used to treat advanced or metastatic prostate cancer. It is commonly prescribed along with prednisone or prednisolone to improve treatment effectiveness and reduce certain side effects. The medicine works by lowering the production of male hormones (androgens) that help prostate cancer cells grow, thereby slowing the progression of the disease.
| Generic name | Abiraterone Acetate |
| Strength | 500 mg |
| Manufacturer | BDR |
| Package size | 60 Tablets |
| Used for | advanced or metastatic prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Abiraterone Acetate is an androgen biosynthesis inhibitor. It works by blocking the CYP17 enzyme, which is involved in the production of testosterone and other male hormones. Since prostate cancer cells depend on these hormones to grow, reducing their levels helps slow or stop cancer growth.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
